Monitoring the cytogenetic architecture of minimal residual plasma cells indicates therapy-induced clonal selection in multiple myeloma

Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group

Antonio Palumbo, Hervé Avet‐Loiseau, Stefania Oliva et al. · Journal of Clinical Oncology · 2015 · 2.2K citations · Full text

Medicine, Hematology, Oncology +16

Treatment of multiple myeloma with high-risk cytogenetics: a consensus of the International Myeloma Working Group

Pieter Sonneveld, Hervé Avet‐Loiseau, Sagar Lonial et al. · Blood · 2016 · 929 citations · Full text

Medicine, Hematology, Oncology +15

Heterogeneity of genomic evolution and mutational profiles in multiple myeloma

Niccolò Bolli, Hervé Avet‐Loiseau, David C. Wedge et al. · Nature Communications · 2014 · 906 citations · Full text

Medicine, Genetics, Oncology +17

Next Generation Flow for highly sensitive and standardized detection of minimal residual disease in multiple myeloma

Juan Flores‐Montero, Luzalba Sanoja-Flores, Bruno Paiva et al. · Leukemia · 2017 · 657 citations · Full text

Medicine, Hematology, Oncology +15

Clonal competition with alternating dominance in multiple myeloma

Jonathan J. Keats, Marta Chesi, Jan B. Egan et al. · Blood · 2012 · 636 citations · Full text

Medicine, Hematology, Immunology +14